newsfilter
← Latest News
GlobeNewswire·

Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain

STAFFORD, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01,